Hemorrhage: Difference between revisions

From IDWiki
(Created page with "==Management== ===Major Hemorrhage=== * Massive hemorrhage protocol ** When to activate: *** GI hemorrhage: 2-4 units uncrossmatched RBCs; if poor response, activate massive hemorrhage protocol *** Non-GI hemorrhage: **** If shock index 1-1.3, give 2-4 units uncrossmatched RBCs; if poor response, activate massive hemorrhage protocol **** If shock index ≥1.4, CAT ≥3, or RI ≥4, then activate massive hemorrhage protocol ** Once activated: *** 4 units pRBC (± tranex...")
 
mNo edit summary
 
Line 20: Line 20:
** GI hemorrhage:
** GI hemorrhage:
*** Hemoglobin >70 g/L
*** Hemoglobin >70 g/L
*** INR <1.8 (non-cirrhosis)
*** [[INR]] <1.8 (non-cirrhosis)
*** Platelets >50 x10E9/L (non-cirrhosis)
*** Platelets >50 x10E9/L (non-cirrhosis)
*** Fibrinogen >1.5 g/L
*** [[Fibrinogen]] >1.5 g/L
** Non-GI hemorrhage
** Non-GI hemorrhage
*** Hemoglobin 80 to 120 g/L
*** Hemoglobin 80 to 120 g/L
*** INR <1.8
*** [[INR]] <1.8
*** Platelets >50 x10E9/L
*** Platelets >50 x10E9/L
*** Fibrinogen >1.5 g/L
*** [[Fibrinogen]] >1.5 g/L
* Reverse anticoagulation
* Reverse anticoagulation
** [[Warfarin]]: [[vitamin K]] 10 mg IV once; [[PCC]] 1000 IU (INR 1.5-3) or 2000 IU (INR 3-5 or unknown) or 3000 IU (INR >5)
** [[Warfarin]]: [[vitamin K]] 10 mg IV once; [[PCC]] 1000 IU ([[INR]] 1.5-3) or 2000 IU ([[INR]] 3-5 or unknown) or 3000 IU ([[INR]] >5)
** [[Dabigatran]]: [[idarucizumab]] 5 g IV once
** [[Dabigatran]]: [[idarucizumab]] 5 g IV once
** Factor Xa inhibitors: [[PCC}} 2000 IU once (or [[andexanet alpha]], if available); repeat PCC at 1 h if ongoing hemorrhage
** Factor Xa inhibitors: [[PCC]] 2000 IU once (or [[andexanet alpha]], if available); repeat [[PCC]] at 1 h if ongoing hemorrhage


[[Category:Hematology]][[Category:Critical care]]
[[Category:Hematology]][[Category:Critical care]]

Latest revision as of 17:22, 10 December 2023

Management

Major Hemorrhage

  • Massive hemorrhage protocol
    • When to activate:
      • GI hemorrhage: 2-4 units uncrossmatched RBCs; if poor response, activate massive hemorrhage protocol
      • Non-GI hemorrhage:
        • If shock index 1-1.3, give 2-4 units uncrossmatched RBCs; if poor response, activate massive hemorrhage protocol
        • If shock index ≥1.4, CAT ≥3, or RI ≥4, then activate massive hemorrhage protocol
    • Once activated:
  • Tranexamic acid
    • For postpartum hemorrhage: tranexamic acid 1 g IV once, repeat at 30 minutes if ongoing bleeding
    • For recent (<3 h) traumatic hemorrhage: tranexamic acid 2 g IV once, ideally within 60 min of injury
    • No GI bleeds, it should not be used routinely
  • Monitoring and targets
    • Repeat blood draws every 30 to 60 minutes
    • GI hemorrhage:
      • Hemoglobin >70 g/L
      • INR <1.8 (non-cirrhosis)
      • Platelets >50 x10E9/L (non-cirrhosis)
      • Fibrinogen >1.5 g/L
    • Non-GI hemorrhage
      • Hemoglobin 80 to 120 g/L
      • INR <1.8
      • Platelets >50 x10E9/L
      • Fibrinogen >1.5 g/L
  • Reverse anticoagulation